Oncology Medical News about 18F-FDG PET

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI
The Journal of Nuclear Medicine, 08/26/09

Cheon GJ et al. – Combined infomration of 18F-FDG PET and MRI scans, acquired before and after chemotherapy, could be used to predict histologic response to neoadjuvant chemotherapy in osteosarcoma.

Methods

70 consecutive patients with a high-grade osteosarcoma
Prospective study
All patients underwent 18F-FDG PET and MRI before and after neoadjuvant chemotherapy

Results

Patients with a SUV2 ≤ 2 had a good histologic response
Patients with a SUV2 > 5 had a poor histologic response
For patients with a SUV2 < 2 and ≤ 5, response was predicted by MVCR
A MVCR < 0.65 was a good responder; a MVCR ὅ 0.65 was a poor responder
The predictive values for good responders and poor responders were 97% and 95%, respectively

Exclusive Author Commentary
Dae-Geun Jeon, 08/19/09

As the PET image is an 3-dimensional value, the idea of combining the volume change during preoperative chemotherapy with PET value is the essence of this study. Furthermore, dividing any cohort into three group might reveal actual situation than binary grouping.

<< Previous
Positron emission tomography in staging early lung cancer

Next >>
The association of breast cancer and meningioma in men and women